Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASD141

NCT06235437 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Solid Tumor

Interventions

BIOLOGICAL: ASD141

Sponsor

Ascendo Biotechnology Co., Ltd.